BUFFALO, NY - Roswell Park Cancer Institute (RPCI) will host a workshop on translational research on Tuesday, November 3, from 8am to 4:30pm in the Zebro Conference Room, Center for Genetics and Pharmacology, on the main RPCI campus.
The presenters include speakers from RPCI as well as GTx, the Ontario Institute for Cancer Research, Hodgson Russ LLP, and Wisconsin Alumni Research Foundation. They will cover topics such as the importance of translational research, the changing landscape of “patentability,” and the challenges and opportunities relating to technology transfer experienced by RPCI.
The program will also include a panel discussion on business creation with representatives from Andro BioSys, Kinex, Empire Genomics, Cleveland Biolabs, and Hodgson Russ LLP, moderated by Dr. Judith Albers, CEO of Excell Partners. The workshop will conclude with a networking session.
For more information or to register, see www.buffaloniagara.org/workshop.
The mission of Roswell Park Cancer Institute (RPCI) is to understand, prevent and cure cancer. RPCI, founded in 1898, was one of the first cancer centers in the country to be named a National Cancer Institute-designated comprehensive cancer center and remains the only facility with this designation in Upstate New York. The Institute is a member of the prestigious National Comprehensive Cancer Network, an alliance of the nation's leading cancer centers; maintains affiliate sites; and is a partner in national and international collaborative programs. For more information, visit RPCI's website at http://www.roswellpark.org, call 1-877-ASK-RPCI (1-877-275-7724) or email email@example.com.
Annie Deck-Miller, Senior Media Relations Manager